(Q47280311)

13 January 2018

title

Insulin use in elderly adults: risk of hypoglycemia and strategies for care (English)

1 reference

13 January 2018

1 reference

1 reference

Robert J Ligthelm

1

1 reference

13 January 2018

Marcel Kaiser

series ordinal

2

1 reference

13 January 2018

Jiten Vora

series ordinal

3

1 reference

13 January 2018

Jean-François Yale

series ordinal

4

1 reference

13 January 2018

language of work or name

English

0 references

publication date

6 August 2012

1 reference

13 January 2018

Journal of the American Geriatrics Society

published in

1 reference

13 January 2018

volume

60

1 reference

13 January 2018

issue

8

1 reference

13 January 2018

page(s)

1564-1570

1 reference

13 January 2018

Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Costs of managing severe hypoglycaemia in three European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Guidelines for Improving the Care of the Older Person with Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Care of elderly patients with diabetes mellitus: a focus on frailty

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Frequent hypoglycemia among elderly patients with poor glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Special considerations for treatment of type 2 diabetes mellitus in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Incretin therapies in the management of elderly patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Self management and patient understanding of diabetes in the older person

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

Self-titration of biphasic insulin aspart 30/70 improves glycaemic control and allows easy intensification in a Dutch clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

The Mini-Cog: receiver operating characteristics with expert and naïve raters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2012.04055.X

10.1111/J.1532-5415.2012.04055.X

21 January 2018

Identifiers

DOI

1 reference

13 January 2018

PubMed ID

22881394

1 reference

13 January 2018